Skip to content

Dr. Reddy's Laboratories Limited Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Thu, Jan 21, 2027, before the market opens · estimates and history

Dr. Reddy's Laboratories Limited · E.DRREDDY.NSE · India
Use symbol E.DRREDDY.NSE in our API & Excel add-in to retrieve this data ↓
1,342.00
(-0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 29.10%

Dr. Reddy's Laboratories Limited Forecast

Dr. Reddy's Laboratories Limited short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 29.1% a year, a typical one-standard-deviation range is 1,287–1,397 over a week, 1,229–1,455 over a month and 951.47–1,733 over a year. (Signals as of 5 Nov 2026.)

Dr. Reddy's Laboratories Limited Price Chart

MacroFinance.ai

Dr. Reddy's Laboratories Limited Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Dr. Reddy's Laboratories Limited
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Dr. Reddy's Laboratories Limited
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Dr. Reddy's Laboratories Limited
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Dr. Reddy's Laboratories Limited
P/E
39.96x
Mid-range vs own history
QoQ +35.3%
YoY +125.7%
now 39.963317.31 low41.4 high
ⓘP/E As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Dr. Reddy's Laboratories Limited
P/S
3.39x
Mid-range vs own history
QoQ +14.8%
YoY +11.7%
now 3.39052.83 low3.51 high
ⓘP/S As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Dr. Reddy's Laboratories Limited
P/B
2.90x
Mid-range vs own history
QoQ +13.5%
YoY 0.0%
now 2.89592.49 low3 high
ⓘP/B As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Dr. Reddy's Laboratories Limited
EV/EBITDA
18.72x
Mid-range vs own history
QoQ +28.9%
YoY +67.6%
now 18.720910.84 low19.4 high
ⓘEV/EBITDA As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Dr. Reddy's Laboratories Limited
EV/Sales
3.38x
Mid-range vs own history
QoQ +15.5%
YoY +12.6%
now 3.37852.82 low3.5 high
ⓘEV/Sales As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Dr. Reddy's Laboratories Limited
FCF Yield
1.0%
Mid-range vs own history
QoQ −31.3%
YoY −51.4%
now 1.03221 low2.85 high
ⓘFCF Yield As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Dr. Reddy's Laboratories Limited
Earnings Yield
2.5%
Mid-range vs own history
QoQ −26.1%
YoY −55.7%
now 2.50232.42 low5.78 high
ⓘEarnings Yield As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Dr. Reddy's Laboratories Limited
Dividend Yield
0.6%
Mid-range vs own history
QoQ −12.5%
YoY −53.6%
now 0.59590.58 low1.36 high
ⓘDividend Yield As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Dr. Reddy's Laboratories Limited
Market Cap
$1.12T
Mid-range vs own history
QoQ +14.3%
YoY +7.7%
now 1118332.886955,990 low1,158,500 high
ⓘMarket Cap As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Dr. Reddy's Laboratories Limited
Net Debt
-$4.0B
High vs own history
QoQ −58.3%
YoY −64.9%
now -3955-11,272 low1,730 high
ⓘNet Debt As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Dr. Reddy's Laboratories Limited
Net Debt / EBITDA
-0.07x
High vs own history
QoQ −53.3%
YoY −45.9%
now -0.0664-0.14 low0.02 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Dr. Reddy's Laboratories Limited
Current Ratio
1.93x
Mid-range vs own history
QoQ +1.2%
YoY +4.0%
now 1.92621.8 low1.93 high
ⓘCurrent Ratio As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Dr. Reddy's Laboratories Limited
Quick Ratio
1.40x
Mid-range vs own history
QoQ +0.7%
YoY +3.8%
now 1.40071.35 low1.4 high
ⓘQuick Ratio As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Dr. Reddy's Laboratories Limited
Interest Coverage
8.46x
Weak vs own history
QoQ −22.5%
YoY −62.7%
now 8.45838.46 low22.68 high
ⓘInterest Coverage As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Dr. Reddy's Laboratories Limited
Debt / Equity
0.19x
Mid-range vs own history
QoQ −0.2%
YoY +14.6%
now 0.18720.16 low0.24 high
ⓘDebt / Equity As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Dr. Reddy's Laboratories Limited
Piotroski F-Score
5
Mid-range vs own history
QoQ 0.0%
YoY +25.0%
now 54 low5 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Dr. Reddy's Laboratories Limited
Altman Z-Score
5.59
Weak vs own history
QoQ +9.4%
YoY −1.8%
now 5.59165.04 low5.79 high
ⓘAltman Z-Score As of 22 Nov 2026.See Dr. Reddy's Laboratories Limited returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Dr. Reddy's Laboratories Limited, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Dr. Reddy's Laboratories Limited fundamentals: income statement, balance sheet & cash flow

Dr. Reddy's Laboratories Limited reported revenue of 335.93bn INR and net income of 42.85bn INR in FY2026, the year ended 31 March 2026 — revenue up 3.2% and net income down 24.2% on the prior year. Free cash flow was 30.51bn INR. These figures are as reported in the filings, not restated: 26 fiscal years and 102 quarters of history, back to March 2001.

Revenue (FY2026)
335.93bn INR
+3.2%
Net income
42.85bn INR
-24.2%
Gross margin
52.77%
Free cash flow
30.51bn INR
+61.2%
Net debt
74.18bn INR
Dr. Reddy's Laboratories Limited income statement, annual, as reported · INR billions unless stated
INR billionsFY2026FY2025FY2024FY2023FY2022
Period end31 Mar 202631 Mar 202531 Mar 202431 Mar 202331 Mar 2022
Revenue335.93325.54279.16245.88214.39
Cost of revenue158.67135.11115.56106.54100.55
Gross profit177.26190.43163.61139.34113.84
Research & development24.0627.3822.8719.3817.48
Operating income46.4471.8467.7357.1429.48
EBITDA79.1690.0980.4365.9247.74
Interest expense3.742.831.711.430.96
Pre-tax income54.8276.7871.8760.3732.30
Income tax12.3519.5416.1915.308.73
Net income42.8556.5455.6845.0723.57

Download Dr. Reddy's Laboratories Limited fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.DRREDDY.NSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 26 fiscal years and 102 quarters, the filing vintages behind each number and API access.
Create free account

Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Dr. Reddy's Laboratories Limited

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Dr. Reddy's Laboratories Limited Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Dr. Reddy's Laboratories Limited; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Dr. Reddy's Laboratories Limited’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Dr. Reddy's Laboratories Limited behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Dr. Reddy's Laboratories Limited (India)

Dr. Reddy's Laboratories Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited is a listed security in India. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Dr. Reddy's Laboratories Limited price?
The latest close is 1,342 (5 Nov 2026), -0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Dr. Reddy's Laboratories Limited in an uptrend?
As of 5 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Dr. Reddy's Laboratories Limited?
20-day realised volatility is 29.1% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 8.4% over a month and 4.1% over a week.
What factors affect Dr. Reddy's Laboratories Limited?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Dr. Reddy's Laboratories Limited, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Dr. Reddy's Laboratories Limited?
28 backtested tactical asset allocation strategies trade Dr. Reddy's Laboratories Limited through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Dr. Reddy's Laboratories Limited returns analysed?
The Statistical Distribution of Returns section shows the distribution of Dr. Reddy's Laboratories Limited daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Dr. Reddy's Laboratories Limited historical data?
In the Free historical data section of this page: the last 10 years of Dr. Reddy's Laboratories Limited daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Dr. Reddy's Laboratories Limited historical data (last 10 years)

Browse or instantly download the last 10 years of Dr. Reddy's Laboratories Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.DRREDDY.NSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-201390.2
2026-11-191400.9
2026-11-181398.2
2026-11-171388
2026-11-161377.9
2026-11-131380
2026-11-121386.6
2026-11-111377
2026-11-091385
2026-11-081370
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.